GAD 65 ANTIBODYTYPE I DIABETES/ SERUM

image not found

NABL Cap Accredited    
The GAD 65 Antibody test by Metropolis Healthcare detects antibodies against glutamic acid decarboxylase, an enzyme in pancreatic beta cells. Elevated levels are associated with Type I diabetes and can indicate autoimmune destruction of insulin-producing cells. This test helps in early diagnosis, risk assessment, and monitoring of disease progression. Metropolis Healthcare provides accurate and reliable immunoassay-based detection for effective diabetes management 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 6,400.00

Sample Type: SERUM

Fasting Not Required


Notes: G0004

Frequently Asked Questions (FAQ's):

What does the GAD 65 Antibody test detect?
It identifies antibodies against pancreatic beta cells, performed with Metropolis Healthcare’s precise immunoassays.

Why is this test important?
It helps diagnose Type I diabetes and assess autoimmune involvement in pancreatic function.

What sample is required?
A serum sample is collected for antibody testing.

Who should take this test?
Individuals with symptoms of Type I diabetes, a family history of autoimmune diabetes, or suspected latent autoimmune diabetes in adults.

Is fasting required?
No fasting is necessary for this antibody test.

How long do results take at Metropolis Healthcare?
Results are typically available within a few working days.

How do the results help?
They guide diagnosis, risk assessment, and management strategies for Type I diabetes.

Can this test be used for monitoring disease progression?

Yes, Metropolis Healthcare can track antibody levels to monitor autoimmune activity over time 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab